Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and COVID-19 disease among people living with HIV: A cross-sectional population-based study by Elisa de Lazzari, Daniel K. Nomah, Jose L. Blanco, Naira Rico, Xabier Filella, Natalia Egri, Raquel Ruiz, Maria Angeles Marcos, Maria del Mar Mosquera, Jose Alcamí, Sonsoles Sánchez-Palomino, Andreu Bruguera, Carmen Hurtado, Cristina Rovira, Juan Ambrosioni, Iván Chivite, Ana González-Cordón, Alexy Inciarte, Montserrat Laguno, María Martínez-Rebollar, Lorena de la Mora, Berta Torres, Yesika Díaz, Esteban Martínez, Josep Mallolas, Jose M. Miro

Get full text